Respiratory syncytial virus (RSV): Overview, treatment, and prevention strategies

Newborn and Infant Nursing Reviews

Volumn 4, Issue 1, 2004, Pages 15-23

  Polak, Mark J ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIPYRETIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHEMOKINE; CORTICOSTEROID; CYTOKINE; DORNASE ALFA; HELIOX; IPRATROPIUM BROMIDE; LUNG SURFACTANT; MUCOLYTIC AGENT; NITRIC OXIDE; ORCIPRENALINE; OXYGEN; PALIVIZUMAB; PERFLUOROOCTYL BROMIDE; PLACEBO; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; RIBAVIRIN; SALBUTAMOL; VIRUS PROTEIN; VIRUS RNA; VIRUS VACCINE;

AIRWAY; ARTIFICIAL VENTILATION; BRONCHIOLITIS; CHILD HEALTH CARE; CHILDHOOD MORTALITY; CLINICAL TRIAL; COMMON COLD; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXPOSURE; EXTRACORPOREAL OXYGENATION; HEALTH EDUCATION; HUMAN; HYDRATION; IMMUNE SYSTEM; IMMUNOPROPHYLAXIS; INFANT; INFANT DISEASE; INFECTION PREVENTION; INFECTION SENSITIVITY; MAINTENANCE THERAPY; MORBIDITY; MUCUS; NONHUMAN; OXYGENATION; PARENT; PHYSIOTHERAPY; POSITIVE END EXPIRATORY PRESSURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; SYMPTOMATOLOGY; TREATMENT PLANNING; VIRUS INFECTION; VIRUS PNEUMONIA;

EID: 1542319043     PISSN: 15273369     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.nainr.2003.12.007     Document Type: Review

References (57)

1. Shay D.K. Holman R.C. Roosevelt G.E. et al. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997 J Infect Dis 183 2001 16
2. Glezen W.P. Couch R.B. Estimating deaths due to influenza and respiratory syncytial virus JAMA 289 2003 2500
3. Shay D.K. Holman R.C. Newman R.D. et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996 JAMA 282 1999 1440-1446
4. Leader S. Kohlhase K. Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999 Pediatr Infect Dis J 21 2002 629-632
5. Black C.P. Systematic review of the biology and medical management of respiratory syncytial virus infection Respir Care 48 2003 209-231
6. Hemming V.G. Respiratory syncytial virus: A brief history in: Weisman L.E. Groothius J.R. (Eds.), Contemporary Diagnosis and Management of Respiratory Syncytial Virus 2000 7-23 Handbooks in Health Care Newton, PA
7. Piedra P.A. Clinical experience with respiratory syncytial virus vaccines Pediatr Infect Dis J 22 2003 S94-S99
8. Eggleston M. Clinical review of ribavirin Infect Control 8 1987 215-218
9. Law B.J. Wang E.E. MacDonald N. et al. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database Pediatrics 99 1997 E7
10. Welliver R.C. Respiratory syncytial virus immunoglobulin and monoclonal antibodies in the prevention and treatment of respiratory syncytial virus infection Semin Perinatol 22 1998 87-95
11. Johnson S. Oliver C. Prince G.A. et al. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus J Infect Dis 176 1997 1215-1224
12. The PREVENT Study Group Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis Pediatrics 99 1997 93-99
13. Connor E.M. IMpact-RSV Study Group Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants Pediatrics 102 1998 531-537
14. Welliver R.C. Respiratory syncytial virus and other respiratory viruses Pediatr Infect Dis J 22 2003 S6-S10
15. Hall C.B. Respiratory syncytial virus and parainfluenza virus N Engl J Med 344 2001 1917-1928
16. Hacking D. Hull J. Respiratory syncytial virus: Viral biology and the host response J Infect Dis 45 2002 18-24
17. Crowe J.E. Williams J.V. Immunology of viral respiratory tract infection in infancy Paediatr Respir Rev 4 2003 112-119
18. Baumeister E.G. Hunicken D.S. Savy V.L. RSV molecular characterization and specific antibody response in young children with acute lower respiratory infection J Clin Virol 27 2003 44-51
19. de Waal L. Koopman L.P. van Benten I.J. et al. Moderate local and systemic respiratory syncytial virus-specific T-cell responses upon mild or subclinical RSV infection J Med Virol 70 2003 309-318
20. Ogilvie M.M. Vathenen A.S. Radford M. et al. Maternal antibody and respiratory syncytial virus infection in infancy J Med Virol 7 1981 263-271
21. Domachowske J.B. Rosenberg H.F. Respiratory syncytial virus infection: Immune response, immunopathogenesis, and treatment Clin Microbiol Rev 12 1999 298-309
22. Nadal D. Ogra P.L. Development of local immunity: Role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections Lung 168S 1990 379-387
23. Toms G.L. Scott R. Respiratory syncytial virus and the infant immune response Arch Dis Child 62 1987 544-546
24. Welliver R.C. Immune response in: Weisman L.E. Groothius J.R. (Eds.), Contemporary Diagnosis and Management of Respiratory Syncytial Virus 2000 94-121 Handbooks in Health Care Newton, PA
25. Adkins B. Bu Y. Guevara P. Generation of Th memory in neonates versus adults: Prolonged primary Th2 effector function and impaired development of Th1 memory effector function in murine neonates J Immunol 166 2001 918-925
26. Culley F.J. Pollott J. Openshaw P.J. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood J Exp Med 196 2002 1381-1386
27. Sigurs N. Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease Respir Res 3 2002 S8-S14
28. Martinez F.D. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma Pediatr Infect Dis J 22 2003 S76-S82
29. Greenough A. Respiratory syncytial virus infection: Clinical features, management, and prophylaxis Curr Opin Pulm Med 8 2002 214-217
30. Kneyber M.C. Brandenburg A.H. de Groot R. et al. Risk factors for respiratory syncytial virus associated apnoea Eur J Pediatr 157 1998 331-335
31. Lindgren C. Grogaard J. Reflex apnoea response and inflammatory mediators in infants with respiratory tract infection Acta Paediatr 85 1996 798-803
32. Hall C.B. Respiratory syncytial virus: A continuing culprit and conundrum J. Pediatr 135 1999 2-7
33. Hodge D. Chetcuti P.A. RSV: Management of the acute episode Paediatr Respir Rev 1 2000 215-220
34. Buckingham S.C. Quasney M.W. Bush A.J. et al. Respiratory syncytial virus infections in the pediatric intensive care unit: Clinical characteristics and risk factors for adverse outcomes Pediatr Crit Care Med 2 2001 318-323
35. Quittell L. Wolfson M.R. Schidlow D. The effectiveness of chest physical therapy (CPT) in infants with bronchiolitis Am Rev Respir Dis 137 1988 406
36. Nasr S.Z. Strouse P.J. Soskolne E. et al. Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis Chest 120 2001 203-208
37. Wang E.E. Milner R. Allen U. et al. Bronchodilators for treatment of mild bronchiolitis: A factorial randomised trial Arch Dis Child 67 1992 289-293
38. Amirav I. Balanov I. Gorenberg M. et al. á Agonist aerosol distribution in respiratory syncytial virus bronchiolitis J Nuclear Med 43 2002 487-491
39. Bertrand P. Aranibar H. Castro E. et al. Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis Pediatr Pulmonol 31 2001 284-288
40. Sanchez I. De Koster J. Powell R.E. et al. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis J Pediatr 122 1993 145-151
41. Numa A.H. Williams G.D. Dakin C.J. The effect of nebulized epinephrine on respiratory mechanics and gas exchange in bronchiolitis Am J Respir Crit Care Med 164 2001 86-91
42. Wright R.B. Pomerantz W.J. Luria J.W. New approaches to respiratory infections in children: Bronchiolitis and croup Emerg Med Clin North Am 20 2002 93-114
43. Garrison M.M. Christakis D.A. Harvey E. et al. Systemic corticosteroids in infant bronchiolitis: A meta-analysis Pediatrics 105 2000 E44
44. Buckingham S.C. Jafri H.S. Bush A.J. et al. A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: Effects on RSV quantity and clinical outcome J Infect Dis 185 2002 1222-1228
45. van Woensel J.B. van Aalderen W.M. de Weerd W. et al. Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus Thorax 58 2003 383-387
46. Red Book: Report of the Committee on Infectious Diseases Pickering L.K. (Ed.), 2003 523-528 American Academy of PediatricsElk Grove Village, IL
47. Hollman G. Shen G. Zeng L. et al. Helium-oxygen improves Clinical Asthma Scores in children with acute bronchiolitis Crit Care Med 26 1998 1731-1736
48. Leclerc F. Scalfaro P. Noizet O. et al. Mechanical ventilatory support in infants with respiratory syncytial virus infection Pediatr Crit Care Med 2 2001 197-204
49. Tibby S.M. Hatherill M. Wright S.M. et al. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis Am J Respir Crit Care Med 162 2000 1251-1256
50. Patel N.R. Hammer J. Nichani S. et al. Effect of inhaled nitric oxide on respiratory mechanics in ventilated infants with RSV bronchiolitis Intensive Care Med 25 1999 81-87
51. Haeberle H.A. Nesti F. Dieterich H.J. et al. Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation Am J Respir Crit Care Med 165 2002 1433-1438
52. Meyer T.A. Warner B.W. Extracorporeal life support for the treatment of viral pneumonia: Collective experience from the ELSO registry. Extracorporeal Life Support Organization J Pediatr Surg 32 1997 232-236
53. Meissner H.C. Welliver R.C. Chartrand S.A. et al. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: A consensus opinion Pediatr Infect Dis J 18 1999 223-231
54. Teare L. Cookson B. Stone S. Hand hygiene Br Med J 323 2001 411-412
55. Blydt-Hansen T. Subbarao K. Quennec P. et al. Recovery of respiratory syncytial virus from stethoscopes by conventional viral culture and polymerase chain reaction Pediatr Infect Dis J 18 1999 164-165
56. Sondheimer H.M. the Cardiac Synagis Study Group: Palivizumab (PV) prevents hospitalization due to respiratory syncytial virus (RSV) in young children with serious congenital heart disease (CHD) Pediatr Cardiol 23 2002 664
57. Romero J.R. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage Pediatr Infect Dis J 22 2003 S46-S54